Product Details
Mabthera Rituximab+++
Rituximab100 mg/10 mL
Injection
ROA
Intravenous
Applicant Name
Roche Products Limited
NRN
A6-0266
Status
Active
Composition
Each 10 mL contains: Rituximab 10 mg Excipients q.s.
ATC Code/ATCvet Code
L01FA01
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 x 1 vial
Product Description
Concentrate for solution for infusion Clear, colorless liquid with pH of 6.2 – 6.8 and osmolality of 324 – 396 mOsmol/kg 6/7/2024 16:32:09 Mabthera Rituximab A6-0266 Injection Intravenous Rituiximab, Polysorbate 80 (produced from genetically modified maize), sodium chloride, sodium citrate, sodium hydroxide, hydrochloric acid, water for injection. 100mg 1x1 vial POM Roche Products Ltd 48/50 Isaac John Street, Ikeja GRA, Credit direct building, 2nd floor Roche Diagnostics GmbH, Mannheim Sandhofer Strasse 116 D-68305 Mannheim, Germany Roche Diagnostics GmbH, Mannheim Sandhofer Strasse 116 D-68305 Mannheim, Germany Germany 21/12/2020 20/12/2025 No L01FA01
Manufacturer Name
Roche Diagnostics GmbH
Manufacturer Country
GERMANY
Approval Date
2020-12-21
Expiry Date
2025-12-20